世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
非注射用医薬品添加剤の世界市場成長率 2023-2029Global Pharmaceutical Excipients for Non-injection Market Growth 2023-2029 非注射用医薬品添加剤の世界市場規模は、2022年の4580.2百万米ドルから2029年には8961百万米ドルに成長すると予測され、2023年から2029年までのCAGRは10.1％と予測されています。 非注射用医薬品添加剤の米国市... もっと見る
サマリー非注射用医薬品添加剤の世界市場規模は、2022年の4580.2百万米ドルから2029年には8961百万米ドルに成長すると予測され、2023年から2029年までのCAGRは10.1％と予測されています。非注射用医薬品添加剤の米国市場は、2023年から2029年までのCAGRで、2022年の100万米ドルから2029年には100万米ドルに増加すると推定されています。 非注射用医薬品の中国市場は、2023年から2029年までの年平均成長率で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。 非注射用医薬品のヨーロッパ市場は、2023年から2029年までの年平均成長率で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。 世界の主要な非注射用医薬品賦形剤は、ダウ、日本ファインケミカル、南京ウェル製薬、江蘇マキシム生物、NOF、クロダ、江蘇ポリ製薬、二康製薬、広州漢方製薬などです。収益面では、世界の大手2社が2022年にほぼ％のシェアを占めています。 医薬品賦形剤とは、医薬品の安定性、バイオアベイラビリティ、口当たり、その他の特性を改善するために製剤に添加される非活性物質です。規制当局によって一般的に安全とみなされる（GRAS）もので、錠剤、カプセル、内服液、外用クリーム、吸入器など、さまざまな剤形に使用されています。 LPI（エルピーアイ）の最新調査レポート「非注射用医薬品の業界予測」は、過去の売上高から2022年の世界の非注射用医薬品の総売上高を検討し、2023年から2029年の非注射用医薬品の売上高予測について地域や市場分野ごとに包括的な分析を提供しています。非注射用医薬品の売上高を地域別、市場分野別、サブセクター別に分類し、世界の非注射用医薬品業界の詳細な分析（百万米ドル）を提供します。 本インサイトレポートでは、世界の非注射用医薬品添加剤の状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにします。また、本レポートでは、加速する世界の非注射用医薬品の市場において、これらの企業の独自のポジションをより良く理解するために、非注射用医薬品のポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てて、主要グローバル企業の戦略を分析しています。 本インサイトレポートでは、非注射用医薬品添加剤の世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、この調査予測は、世界の非注射用医薬品添加剤の現状と将来の軌道について非常にニュアンスのある見方を提供します。 本レポートでは、非注射用医薬品添加剤市場の製品タイプ、用途、主要メーカー、主要地域、国別の包括的な概要、市場シェア、成長機会について紹介します。 市場のセグメンテーション タイプ別セグメント 結合剤 崩壊剤（Disintegrants 滑沢剤 充填剤 その他 用途別セグメント 錠剤 カプセル剤 内服液剤 その他 また、本レポートでは、地域別に市場を分割しています： 米州 アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア 欧州 ドイツ フランス イギリス イタリア ロシア 中近東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報に基づいて選択されており、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析したものである。 ダウ 日本ファインケミカル 南京ウェル製薬 江蘇マキシムバイオロジカル（Jiangsu Maxim Biological 日油 クロダ 江蘇ポリ製薬 二康製薬 広州漢方製薬 プファンスティール 西安リバング製薬 浙江省天宇山薬用オイル 本レポートで取り上げる主な質問 世界の非注射用医薬品添加剤市場の10年後の展望は？ 世界および地域別に、非注射用医薬品添加剤市場の成長を促進する要因は何か？ 市場別、地域別に最も速い成長を遂げる技術は何か？ 非注射用医薬品添加剤の市場機会は、最終市場規模によってどのように変化するか？ 非注射用医薬品添加剤のタイプ別、用途別内訳は？ COVID-19とロシア・ウクライナ戦争の影響とは？ 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Pharmaceutical Excipients for Non-injection by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Pharmaceutical Excipients for Non-injection by Country/Region, 2018, 2022 & 2029 2.2 Pharmaceutical Excipients for Non-injection Segment by Type 2.2.1 Binders 2.2.2 Disintegrants 2.2.3 Lubricants 2.2.4 Fillers 2.2.5 Others 2.3 Pharmaceutical Excipients for Non-injection Sales by Type 2.3.1 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023) 2.3.2 Global Pharmaceutical Excipients for Non-injection Revenue and Market Share by Type (2018-2023) 2.3.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Type (2018-2023) 2.4 Pharmaceutical Excipients for Non-injection Segment by Application 2.4.1 Tablets 2.4.2 Capsules 2.4.3 Oral Liquids 2.4.4 Others 2.5 Pharmaceutical Excipients for Non-injection Sales by Application 2.5.1 Global Pharmaceutical Excipients for Non-injection Sale Market Share by Application (2018-2023) 2.5.2 Global Pharmaceutical Excipients for Non-injection Revenue and Market Share by Application (2018-2023) 2.5.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Application (2018-2023) 3 Global Pharmaceutical Excipients for Non-injection by Company 3.1 Global Pharmaceutical Excipients for Non-injection Breakdown Data by Company 3.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Company (2018-2023) 3.1.2 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company (2018-2023) 3.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Company (2018-2023) 3.2.1 Global Pharmaceutical Excipients for Non-injection Revenue by Company (2018-2023) 3.2.2 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company (2018-2023) 3.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Company 3.4 Key Manufacturers Pharmaceutical Excipients for Non-injection Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Pharmaceutical Excipients for Non-injection Product Location Distribution 3.4.2 Players Pharmaceutical Excipients for Non-injection Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Pharmaceutical Excipients for Non-injection by Geographic Region 4.1 World Historic Pharmaceutical Excipients for Non-injection Market Size by Geographic Region (2018-2023) 4.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Pharmaceutical Excipients for Non-injection Market Size by Country/Region (2018-2023) 4.2.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Country/Region (2018-2023) 4.2.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Country/Region (2018-2023) 4.3 Americas Pharmaceutical Excipients for Non-injection Sales Growth 4.4 APAC Pharmaceutical Excipients for Non-injection Sales Growth 4.5 Europe Pharmaceutical Excipients for Non-injection Sales Growth 4.6 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Growth 5 Americas 5.1 Americas Pharmaceutical Excipients for Non-injection Sales by Country 5.1.1 Americas Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) 5.1.2 Americas Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) 5.2 Americas Pharmaceutical Excipients for Non-injection Sales by Type 5.3 Americas Pharmaceutical Excipients for Non-injection Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Pharmaceutical Excipients for Non-injection Sales by Region 6.1.1 APAC Pharmaceutical Excipients for Non-injection Sales by Region (2018-2023) 6.1.2 APAC Pharmaceutical Excipients for Non-injection Revenue by Region (2018-2023) 6.2 APAC Pharmaceutical Excipients for Non-injection Sales by Type 6.3 APAC Pharmaceutical Excipients for Non-injection Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Pharmaceutical Excipients for Non-injection by Country 7.1.1 Europe Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) 7.1.2 Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) 7.2 Europe Pharmaceutical Excipients for Non-injection Sales by Type 7.3 Europe Pharmaceutical Excipients for Non-injection Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Pharmaceutical Excipients for Non-injection by Country 8.1.1 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) 8.1.2 Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) 8.2 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Type 8.3 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Non-injection 10.3 Manufacturing Process Analysis of Pharmaceutical Excipients for Non-injection 10.4 Industry Chain Structure of Pharmaceutical Excipients for Non-injection 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Pharmaceutical Excipients for Non-injection Distributors 11.3 Pharmaceutical Excipients for Non-injection Customer 12 World Forecast Review for Pharmaceutical Excipients for Non-injection by Geographic Region 12.1 Global Pharmaceutical Excipients for Non-injection Market Size Forecast by Region 12.1.1 Global Pharmaceutical Excipients for Non-injection Forecast by Region (2024-2029) 12.1.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Pharmaceutical Excipients for Non-injection Forecast by Type 12.7 Global Pharmaceutical Excipients for Non-injection Forecast by Application 13 Key Players Analysis 13.1 Dow 13.1.1 Dow Company Information 13.1.2 Dow Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.1.3 Dow Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Dow Main Business Overview 13.1.5 Dow Latest Developments 13.2 Nippon Fine Chemical 13.2.1 Nippon Fine Chemical Company Information 13.2.2 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.2.3 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Nippon Fine Chemical Main Business Overview 13.2.5 Nippon Fine Chemical Latest Developments 13.3 Nanjing Well Pharmaceutical 13.3.1 Nanjing Well Pharmaceutical Company Information 13.3.2 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.3.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Nanjing Well Pharmaceutical Main Business Overview 13.3.5 Nanjing Well Pharmaceutical Latest Developments 13.4 Jiangsu Maxim Biological 13.4.1 Jiangsu Maxim Biological Company Information 13.4.2 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.4.3 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Jiangsu Maxim Biological Main Business Overview 13.4.5 Jiangsu Maxim Biological Latest Developments 13.5 NOF 13.5.1 NOF Company Information 13.5.2 NOF Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.5.3 NOF Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 NOF Main Business Overview 13.5.5 NOF Latest Developments 13.6 Croda 13.6.1 Croda Company Information 13.6.2 Croda Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.6.3 Croda Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Croda Main Business Overview 13.6.5 Croda Latest Developments 13.7 Jiangsu Poly Pharmaceutical 13.7.1 Jiangsu Poly Pharmaceutical Company Information 13.7.2 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.7.3 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Jiangsu Poly Pharmaceutical Main Business Overview 13.7.5 Jiangsu Poly Pharmaceutical Latest Developments 13.8 Er Kang Pharmaceutical 13.8.1 Er Kang Pharmaceutical Company Information 13.8.2 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.8.3 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Er Kang Pharmaceutical Main Business Overview 13.8.5 Er Kang Pharmaceutical Latest Developments 13.9 Guangzhou Hanfang Pharmaceutical 13.9.1 Guangzhou Hanfang Pharmaceutical Company Information 13.9.2 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.9.3 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Guangzhou Hanfang Pharmaceutical Main Business Overview 13.9.5 Guangzhou Hanfang Pharmaceutical Latest Developments 13.10 Pfanstiehl 13.10.1 Pfanstiehl Company Information 13.10.2 Pfanstiehl Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.10.3 Pfanstiehl Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Pfanstiehl Main Business Overview 13.10.5 Pfanstiehl Latest Developments 13.11 Xi'an Libang Pharmaceutical 13.11.1 Xi'an Libang Pharmaceutical Company Information 13.11.2 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.11.3 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Xi'an Libang Pharmaceutical Main Business Overview 13.11.5 Xi'an Libang Pharmaceutical Latest Developments 13.12 Zhejiang Tianyushan Medicinal Oil 13.12.1 Zhejiang Tianyushan Medicinal Oil Company Information 13.12.2 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.12.3 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Zhejiang Tianyushan Medicinal Oil Main Business Overview 13.12.5 Zhejiang Tianyushan Medicinal Oil Latest Developments 14 Research Findings and Conclusion 図表リストList of TablesTable 1. Pharmaceutical Excipients for Non-injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Pharmaceutical Excipients for Non-injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Binders Table 4. Major Players of Disintegrants Table 5. Major Players of Lubricants Table 6. Major Players of Fillers Table 7. Major Players of Others Table 8. Global Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units) Table 9. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023) Table 10. Global Pharmaceutical Excipients for Non-injection Revenue by Type (2018-2023) & ($ million) Table 11. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2018-2023) Table 12. Global Pharmaceutical Excipients for Non-injection Sale Price by Type (2018-2023) & (US$/Unit) Table 13. Global Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units) Table 14. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023) Table 15. Global Pharmaceutical Excipients for Non-injection Revenue by Application (2018-2023) Table 16. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application (2018-2023) Table 17. Global Pharmaceutical Excipients for Non-injection Sale Price by Application (2018-2023) & (US$/Unit) Table 18. Global Pharmaceutical Excipients for Non-injection Sales by Company (2018-2023) & (K Units) Table 19. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company (2018-2023) Table 20. Global Pharmaceutical Excipients for Non-injection Revenue by Company (2018-2023) ($ Millions) Table 21. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company (2018-2023) Table 22. Global Pharmaceutical Excipients for Non-injection Sale Price by Company (2018-2023) & (US$/Unit) Table 23. Key Manufacturers Pharmaceutical Excipients for Non-injection Producing Area Distribution and Sales Area Table 24. Players Pharmaceutical Excipients for Non-injection Products Offered Table 25. Pharmaceutical Excipients for Non-injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 26. New Products and Potential Entrants Table 27. Mergers & Acquisitions, Expansion Table 28. Global Pharmaceutical Excipients for Non-injection Sales by Geographic Region (2018-2023) & (K Units) Table 29. Global Pharmaceutical Excipients for Non-injection Sales Market Share Geographic Region (2018-2023) Table 30. Global Pharmaceutical Excipients for Non-injection Revenue by Geographic Region (2018-2023) & ($ millions) Table 31. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Geographic Region (2018-2023) Table 32. Global Pharmaceutical Excipients for Non-injection Sales by Country/Region (2018-2023) & (K Units) Table 33. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Country/Region (2018-2023) Table 34. Global Pharmaceutical Excipients for Non-injection Revenue by Country/Region (2018-2023) & ($ millions) Table 35. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Country/Region (2018-2023) Table 36. Americas Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) & (K Units) Table 37. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2018-2023) Table 38. Americas Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) & ($ Millions) Table 39. Americas Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2018-2023) Table 40. Americas Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units) Table 41. Americas Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units) Table 42. APAC Pharmaceutical Excipients for Non-injection Sales by Region (2018-2023) & (K Units) Table 43. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2018-2023) Table 44. APAC Pharmaceutical Excipients for Non-injection Revenue by Region (2018-2023) & ($ Millions) Table 45. APAC Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2018-2023) Table 46. APAC Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units) Table 47. APAC Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units) Table 48. Europe Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) & (K Units) Table 49. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2018-2023) Table 50. Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) & ($ Millions) Table 51. Europe Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2018-2023) Table 52. Europe Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units) Table 53. Europe Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units) Table 54. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) & (K Units) Table 55. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2018-2023) Table 56. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) & ($ Millions) Table 57. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2018-2023) Table 58. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units) Table 59. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units) Table 60. Key Market Drivers & Growth Opportunities of Pharmaceutical Excipients for Non-injection Table 61. Key Market Challenges & Risks of Pharmaceutical Excipients for Non-injection Table 62. Key Industry Trends of Pharmaceutical Excipients for Non-injection Table 63. Pharmaceutical Excipients for Non-injection Raw Material Table 64. Key Suppliers of Raw Materials Table 65. Pharmaceutical Excipients for Non-injection Distributors List Table 66. Pharmaceutical Excipients for Non-injection Customer List Table 67. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Region (2024-2029) & (K Units) Table 68. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Region (2024-2029) & ($ millions) Table 69. Americas Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2024-2029) & (K Units) Table 70. Americas Pharmaceutical Excipients for Non-injection Revenue Forecast by Country (2024-2029) & ($ millions) Table 71. APAC Pharmaceutical Excipients for Non-injection Sales Forecast by Region (2024-2029) & (K Units) Table 72. APAC Pharmaceutical Excipients for Non-injection Revenue Forecast by Region (2024-2029) & ($ millions) Table 73. Europe Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2024-2029) & (K Units) Table 74. Europe Pharmaceutical Excipients for Non-injection Revenue Forecast by Country (2024-2029) & ($ millions) Table 75. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2024-2029) & (K Units) Table 76. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue Forecast by Country (2024-2029) & ($ millions) Table 77. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Type (2024-2029) & (K Units) Table 78. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Type (2024-2029) & ($ Millions) Table 79. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Application (2024-2029) & (K Units) Table 80. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Application (2024-2029) & ($ Millions) Table 81. Dow Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 82. Dow Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 83. Dow Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 84. Dow Main Business Table 85. Dow Latest Developments Table 86. Nippon Fine Chemical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 87. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 88. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 89. Nippon Fine Chemical Main Business Table 90. Nippon Fine Chemical Latest Developments Table 91. Nanjing Well Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 92. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 93. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 94. Nanjing Well Pharmaceutical Main Business Table 95. Nanjing Well Pharmaceutical Latest Developments Table 96. Jiangsu Maxim Biological Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 97. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 98. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 99. Jiangsu Maxim Biological Main Business Table 100. Jiangsu Maxim Biological Latest Developments Table 101. NOF Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 102. NOF Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 103. NOF Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 104. NOF Main Business Table 105. NOF Latest Developments Table 106. Croda Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 107. Croda Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 108. Croda Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 109. Croda Main Business Table 110. Croda Latest Developments Table 111. Jiangsu Poly Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 112. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 113. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 114. Jiangsu Poly Pharmaceutical Main Business Table 115. Jiangsu Poly Pharmaceutical Latest Developments Table 116. Er Kang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 117. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 118. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 119. Er Kang Pharmaceutical Main Business Table 120. Er Kang Pharmaceutical Latest Developments Table 121. Guangzhou Hanfang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 122. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 123. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 124. Guangzhou Hanfang Pharmaceutical Main Business Table 125. Guangzhou Hanfang Pharmaceutical Latest Developments Table 126. Pfanstiehl Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 127. Pfanstiehl Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 128. Pfanstiehl Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 129. Pfanstiehl Main Business Table 130. Pfanstiehl Latest Developments Table 131. Xi'an Libang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 132. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 133. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 134. Xi'an Libang Pharmaceutical Main Business Table 135. Xi'an Libang Pharmaceutical Latest Developments Table 136. Zhejiang Tianyushan Medicinal Oil Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 137. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 138. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 139. Zhejiang Tianyushan Medicinal Oil Main Business Table 140. Zhejiang Tianyushan Medicinal Oil Latest Developments List of Figures Figure 1. Picture of Pharmaceutical Excipients for Non-injection Figure 2. Pharmaceutical Excipients for Non-injection Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Pharmaceutical Excipients for Non-injection Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Pharmaceutical Excipients for Non-injection Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Pharmaceutical Excipients for Non-injection Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Binders Figure 10. Product Picture of Disintegrants Figure 11. Product Picture of Lubricants Figure 12. Product Picture of Fillers Figure 13. Product Picture of Others Figure 14. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type in 2022 Figure 15. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2018-2023) Figure 16. Pharmaceutical Excipients for Non-injection Consumed in Tablets Figure 17. Global Pharmaceutical Excipients for Non-injection Market: Tablets (2018-2023) & (K Units) Figure 18. Pharmaceutical Excipients for Non-injection Consumed in Capsules Figure 19. Global Pharmaceutical Excipients for Non-injection Market: Capsules (2018-2023) & (K Units) Figure 20. Pharmaceutical Excipients for Non-injection Consumed in Oral Liquids Figure 21. Global Pharmaceutical Excipients for Non-injection Market: Oral Liquids (2018-2023) & (K Units) Figure 22. Pharmaceutical Excipients for Non-injection Consumed in Others Figure 23. Global Pharmaceutical Excipients for Non-injection Market: Others (2018-2023) & (K Units) Figure 24. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2022) Figure 25. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application in 2022 Figure 26. Pharmaceutical Excipients for Non-injection Sales Market by Company in 2022 (K Units) Figure 27. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company in 2022 Figure 28. Pharmaceutical Excipients for Non-injection Revenue Market by Company in 2022 ($ Million) Figure 29. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company in 2022 Figure 30. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Geographic Region (2018-2023) Figure 31. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Geographic Region in 2022 Figure 32. Americas Pharmaceutical Excipients for Non-injection Sales 2018-2023 (K Units) Figure 33. Americas Pharmaceutical Excipients for Non-injection Revenue 2018-2023 ($ Millions) Figure 34. APAC Pharmaceutical Excipients for Non-injection Sales 2018-2023 (K Units) Figure 35. APAC Pharmaceutical Excipients for Non-injection Revenue 2018-2023 ($ Millions) Figure 36. Europe Pharmaceutical Excipients for Non-injection Sales 2018-2023 (K Units) Figure 37. Europe Pharmaceutical Excipients for Non-injection Revenue 2018-2023 ($ Millions) Figure 38. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales 2018-2023 (K Units) Figure 39. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue 2018-2023 ($ Millions) Figure 40. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Country in 2022 Figure 41. Americas Pharmaceutical Excipients for Non-injection Revenue Market Share by Country in 2022 Figure 42. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023) Figure 43. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023) Figure 44. United States Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 45. Canada Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 46. Mexico Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 47. Brazil Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 48. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Region in 2022 Figure 49. APAC Pharmaceutical Excipients for Non-injection Revenue Market Share by Regions in 2022 Figure 50. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023) Figure 51. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023) Figure 52. China Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 53. Japan Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 54. South Korea Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 55. Southeast Asia Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 56. India Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 57. Australia Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 58. China Taiwan Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 59. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Country in 2022 Figure 60. Europe Pharmaceutical Excipients for Non-injection Revenue Market Share by Country in 2022 Figure 61. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023) Figure 62. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023) Figure 63. Germany Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 64. France Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 65. UK Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 66. Italy Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 67. Russia Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 68. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Country in 2022 Figure 69. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue Market Share by Country in 2022 Figure 70. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023) Figure 71. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023) Figure 72. Egypt Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 73. South Africa Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 74. Israel Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 75. Turkey Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 76. GCC Country Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 77. Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Non-injection in 2022 Figure 78. Manufacturing Process Analysis of Pharmaceutical Excipients for Non-injection Figure 79. Industry Chain Structure of Pharmaceutical Excipients for Non-injection Figure 80. Channels of Distribution Figure 81. Global Pharmaceutical Excipients for Non-injection Sales Market Forecast by Region (2024-2029) Figure 82. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Region (2024-2029) Figure 83. Global Pharmaceutical Excipients for Non-injection Sales Market Share Forecast by Type (2024-2029) Figure 84. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Type (2024-2029) Figure 85. Global Pharmaceutical Excipients for Non-injection Sales Market Share Forecast by Application (2024-2029) Figure 86. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Application (2024-2029)
SummaryThe global Pharmaceutical Excipients for Non-injection market size is projected to grow from US$ 4580.2 million in 2022 to US$ 8961 million in 2029; it is expected to grow at a CAGR of 10.1% from 2023 to 2029. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Pharmaceutical Excipients for Non-injection by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Pharmaceutical Excipients for Non-injection by Country/Region, 2018, 2022 & 2029 2.2 Pharmaceutical Excipients for Non-injection Segment by Type 2.2.1 Binders 2.2.2 Disintegrants 2.2.3 Lubricants 2.2.4 Fillers 2.2.5 Others 2.3 Pharmaceutical Excipients for Non-injection Sales by Type 2.3.1 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023) 2.3.2 Global Pharmaceutical Excipients for Non-injection Revenue and Market Share by Type (2018-2023) 2.3.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Type (2018-2023) 2.4 Pharmaceutical Excipients for Non-injection Segment by Application 2.4.1 Tablets 2.4.2 Capsules 2.4.3 Oral Liquids 2.4.4 Others 2.5 Pharmaceutical Excipients for Non-injection Sales by Application 2.5.1 Global Pharmaceutical Excipients for Non-injection Sale Market Share by Application (2018-2023) 2.5.2 Global Pharmaceutical Excipients for Non-injection Revenue and Market Share by Application (2018-2023) 2.5.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Application (2018-2023) 3 Global Pharmaceutical Excipients for Non-injection by Company 3.1 Global Pharmaceutical Excipients for Non-injection Breakdown Data by Company 3.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Company (2018-2023) 3.1.2 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company (2018-2023) 3.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Company (2018-2023) 3.2.1 Global Pharmaceutical Excipients for Non-injection Revenue by Company (2018-2023) 3.2.2 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company (2018-2023) 3.3 Global Pharmaceutical Excipients for Non-injection Sale Price by Company 3.4 Key Manufacturers Pharmaceutical Excipients for Non-injection Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Pharmaceutical Excipients for Non-injection Product Location Distribution 3.4.2 Players Pharmaceutical Excipients for Non-injection Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Pharmaceutical Excipients for Non-injection by Geographic Region 4.1 World Historic Pharmaceutical Excipients for Non-injection Market Size by Geographic Region (2018-2023) 4.1.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Pharmaceutical Excipients for Non-injection Market Size by Country/Region (2018-2023) 4.2.1 Global Pharmaceutical Excipients for Non-injection Annual Sales by Country/Region (2018-2023) 4.2.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue by Country/Region (2018-2023) 4.3 Americas Pharmaceutical Excipients for Non-injection Sales Growth 4.4 APAC Pharmaceutical Excipients for Non-injection Sales Growth 4.5 Europe Pharmaceutical Excipients for Non-injection Sales Growth 4.6 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Growth 5 Americas 5.1 Americas Pharmaceutical Excipients for Non-injection Sales by Country 5.1.1 Americas Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) 5.1.2 Americas Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) 5.2 Americas Pharmaceutical Excipients for Non-injection Sales by Type 5.3 Americas Pharmaceutical Excipients for Non-injection Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Pharmaceutical Excipients for Non-injection Sales by Region 6.1.1 APAC Pharmaceutical Excipients for Non-injection Sales by Region (2018-2023) 6.1.2 APAC Pharmaceutical Excipients for Non-injection Revenue by Region (2018-2023) 6.2 APAC Pharmaceutical Excipients for Non-injection Sales by Type 6.3 APAC Pharmaceutical Excipients for Non-injection Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Pharmaceutical Excipients for Non-injection by Country 7.1.1 Europe Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) 7.1.2 Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) 7.2 Europe Pharmaceutical Excipients for Non-injection Sales by Type 7.3 Europe Pharmaceutical Excipients for Non-injection Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Pharmaceutical Excipients for Non-injection by Country 8.1.1 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) 8.1.2 Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) 8.2 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Type 8.3 Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Non-injection 10.3 Manufacturing Process Analysis of Pharmaceutical Excipients for Non-injection 10.4 Industry Chain Structure of Pharmaceutical Excipients for Non-injection 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Pharmaceutical Excipients for Non-injection Distributors 11.3 Pharmaceutical Excipients for Non-injection Customer 12 World Forecast Review for Pharmaceutical Excipients for Non-injection by Geographic Region 12.1 Global Pharmaceutical Excipients for Non-injection Market Size Forecast by Region 12.1.1 Global Pharmaceutical Excipients for Non-injection Forecast by Region (2024-2029) 12.1.2 Global Pharmaceutical Excipients for Non-injection Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Pharmaceutical Excipients for Non-injection Forecast by Type 12.7 Global Pharmaceutical Excipients for Non-injection Forecast by Application 13 Key Players Analysis 13.1 Dow 13.1.1 Dow Company Information 13.1.2 Dow Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.1.3 Dow Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Dow Main Business Overview 13.1.5 Dow Latest Developments 13.2 Nippon Fine Chemical 13.2.1 Nippon Fine Chemical Company Information 13.2.2 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.2.3 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Nippon Fine Chemical Main Business Overview 13.2.5 Nippon Fine Chemical Latest Developments 13.3 Nanjing Well Pharmaceutical 13.3.1 Nanjing Well Pharmaceutical Company Information 13.3.2 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.3.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Nanjing Well Pharmaceutical Main Business Overview 13.3.5 Nanjing Well Pharmaceutical Latest Developments 13.4 Jiangsu Maxim Biological 13.4.1 Jiangsu Maxim Biological Company Information 13.4.2 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.4.3 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Jiangsu Maxim Biological Main Business Overview 13.4.5 Jiangsu Maxim Biological Latest Developments 13.5 NOF 13.5.1 NOF Company Information 13.5.2 NOF Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.5.3 NOF Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 NOF Main Business Overview 13.5.5 NOF Latest Developments 13.6 Croda 13.6.1 Croda Company Information 13.6.2 Croda Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.6.3 Croda Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Croda Main Business Overview 13.6.5 Croda Latest Developments 13.7 Jiangsu Poly Pharmaceutical 13.7.1 Jiangsu Poly Pharmaceutical Company Information 13.7.2 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.7.3 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Jiangsu Poly Pharmaceutical Main Business Overview 13.7.5 Jiangsu Poly Pharmaceutical Latest Developments 13.8 Er Kang Pharmaceutical 13.8.1 Er Kang Pharmaceutical Company Information 13.8.2 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.8.3 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Er Kang Pharmaceutical Main Business Overview 13.8.5 Er Kang Pharmaceutical Latest Developments 13.9 Guangzhou Hanfang Pharmaceutical 13.9.1 Guangzhou Hanfang Pharmaceutical Company Information 13.9.2 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.9.3 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Guangzhou Hanfang Pharmaceutical Main Business Overview 13.9.5 Guangzhou Hanfang Pharmaceutical Latest Developments 13.10 Pfanstiehl 13.10.1 Pfanstiehl Company Information 13.10.2 Pfanstiehl Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.10.3 Pfanstiehl Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Pfanstiehl Main Business Overview 13.10.5 Pfanstiehl Latest Developments 13.11 Xi'an Libang Pharmaceutical 13.11.1 Xi'an Libang Pharmaceutical Company Information 13.11.2 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.11.3 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Xi'an Libang Pharmaceutical Main Business Overview 13.11.5 Xi'an Libang Pharmaceutical Latest Developments 13.12 Zhejiang Tianyushan Medicinal Oil 13.12.1 Zhejiang Tianyushan Medicinal Oil Company Information 13.12.2 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications 13.12.3 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Zhejiang Tianyushan Medicinal Oil Main Business Overview 13.12.5 Zhejiang Tianyushan Medicinal Oil Latest Developments 14 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Pharmaceutical Excipients for Non-injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Pharmaceutical Excipients for Non-injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Binders Table 4. Major Players of Disintegrants Table 5. Major Players of Lubricants Table 6. Major Players of Fillers Table 7. Major Players of Others Table 8. Global Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units) Table 9. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023) Table 10. Global Pharmaceutical Excipients for Non-injection Revenue by Type (2018-2023) & ($ million) Table 11. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2018-2023) Table 12. Global Pharmaceutical Excipients for Non-injection Sale Price by Type (2018-2023) & (US$/Unit) Table 13. Global Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units) Table 14. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023) Table 15. Global Pharmaceutical Excipients for Non-injection Revenue by Application (2018-2023) Table 16. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application (2018-2023) Table 17. Global Pharmaceutical Excipients for Non-injection Sale Price by Application (2018-2023) & (US$/Unit) Table 18. Global Pharmaceutical Excipients for Non-injection Sales by Company (2018-2023) & (K Units) Table 19. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company (2018-2023) Table 20. Global Pharmaceutical Excipients for Non-injection Revenue by Company (2018-2023) ($ Millions) Table 21. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company (2018-2023) Table 22. Global Pharmaceutical Excipients for Non-injection Sale Price by Company (2018-2023) & (US$/Unit) Table 23. Key Manufacturers Pharmaceutical Excipients for Non-injection Producing Area Distribution and Sales Area Table 24. Players Pharmaceutical Excipients for Non-injection Products Offered Table 25. Pharmaceutical Excipients for Non-injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 26. New Products and Potential Entrants Table 27. Mergers & Acquisitions, Expansion Table 28. Global Pharmaceutical Excipients for Non-injection Sales by Geographic Region (2018-2023) & (K Units) Table 29. Global Pharmaceutical Excipients for Non-injection Sales Market Share Geographic Region (2018-2023) Table 30. Global Pharmaceutical Excipients for Non-injection Revenue by Geographic Region (2018-2023) & ($ millions) Table 31. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Geographic Region (2018-2023) Table 32. Global Pharmaceutical Excipients for Non-injection Sales by Country/Region (2018-2023) & (K Units) Table 33. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Country/Region (2018-2023) Table 34. Global Pharmaceutical Excipients for Non-injection Revenue by Country/Region (2018-2023) & ($ millions) Table 35. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Country/Region (2018-2023) Table 36. Americas Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) & (K Units) Table 37. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2018-2023) Table 38. Americas Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) & ($ Millions) Table 39. Americas Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2018-2023) Table 40. Americas Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units) Table 41. Americas Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units) Table 42. APAC Pharmaceutical Excipients for Non-injection Sales by Region (2018-2023) & (K Units) Table 43. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2018-2023) Table 44. APAC Pharmaceutical Excipients for Non-injection Revenue by Region (2018-2023) & ($ Millions) Table 45. APAC Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2018-2023) Table 46. APAC Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units) Table 47. APAC Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units) Table 48. Europe Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) & (K Units) Table 49. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2018-2023) Table 50. Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) & ($ Millions) Table 51. Europe Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2018-2023) Table 52. Europe Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units) Table 53. Europe Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units) Table 54. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Country (2018-2023) & (K Units) Table 55. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2018-2023) Table 56. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2018-2023) & ($ Millions) Table 57. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2018-2023) Table 58. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Type (2018-2023) & (K Units) Table 59. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales by Application (2018-2023) & (K Units) Table 60. Key Market Drivers & Growth Opportunities of Pharmaceutical Excipients for Non-injection Table 61. Key Market Challenges & Risks of Pharmaceutical Excipients for Non-injection Table 62. Key Industry Trends of Pharmaceutical Excipients for Non-injection Table 63. Pharmaceutical Excipients for Non-injection Raw Material Table 64. Key Suppliers of Raw Materials Table 65. Pharmaceutical Excipients for Non-injection Distributors List Table 66. Pharmaceutical Excipients for Non-injection Customer List Table 67. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Region (2024-2029) & (K Units) Table 68. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Region (2024-2029) & ($ millions) Table 69. Americas Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2024-2029) & (K Units) Table 70. Americas Pharmaceutical Excipients for Non-injection Revenue Forecast by Country (2024-2029) & ($ millions) Table 71. APAC Pharmaceutical Excipients for Non-injection Sales Forecast by Region (2024-2029) & (K Units) Table 72. APAC Pharmaceutical Excipients for Non-injection Revenue Forecast by Region (2024-2029) & ($ millions) Table 73. Europe Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2024-2029) & (K Units) Table 74. Europe Pharmaceutical Excipients for Non-injection Revenue Forecast by Country (2024-2029) & ($ millions) Table 75. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Forecast by Country (2024-2029) & (K Units) Table 76. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue Forecast by Country (2024-2029) & ($ millions) Table 77. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Type (2024-2029) & (K Units) Table 78. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Type (2024-2029) & ($ Millions) Table 79. Global Pharmaceutical Excipients for Non-injection Sales Forecast by Application (2024-2029) & (K Units) Table 80. Global Pharmaceutical Excipients for Non-injection Revenue Forecast by Application (2024-2029) & ($ Millions) Table 81. Dow Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 82. Dow Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 83. Dow Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 84. Dow Main Business Table 85. Dow Latest Developments Table 86. Nippon Fine Chemical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 87. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 88. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 89. Nippon Fine Chemical Main Business Table 90. Nippon Fine Chemical Latest Developments Table 91. Nanjing Well Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 92. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 93. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 94. Nanjing Well Pharmaceutical Main Business Table 95. Nanjing Well Pharmaceutical Latest Developments Table 96. Jiangsu Maxim Biological Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 97. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 98. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 99. Jiangsu Maxim Biological Main Business Table 100. Jiangsu Maxim Biological Latest Developments Table 101. NOF Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 102. NOF Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 103. NOF Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 104. NOF Main Business Table 105. NOF Latest Developments Table 106. Croda Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 107. Croda Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 108. Croda Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 109. Croda Main Business Table 110. Croda Latest Developments Table 111. Jiangsu Poly Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 112. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 113. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 114. Jiangsu Poly Pharmaceutical Main Business Table 115. Jiangsu Poly Pharmaceutical Latest Developments Table 116. Er Kang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 117. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 118. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 119. Er Kang Pharmaceutical Main Business Table 120. Er Kang Pharmaceutical Latest Developments Table 121. Guangzhou Hanfang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 122. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 123. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 124. Guangzhou Hanfang Pharmaceutical Main Business Table 125. Guangzhou Hanfang Pharmaceutical Latest Developments Table 126. Pfanstiehl Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 127. Pfanstiehl Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 128. Pfanstiehl Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 129. Pfanstiehl Main Business Table 130. Pfanstiehl Latest Developments Table 131. Xi'an Libang Pharmaceutical Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 132. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 133. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 134. Xi'an Libang Pharmaceutical Main Business Table 135. Xi'an Libang Pharmaceutical Latest Developments Table 136. Zhejiang Tianyushan Medicinal Oil Basic Information, Pharmaceutical Excipients for Non-injection Manufacturing Base, Sales Area and Its Competitors Table 137. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Portfolios and Specifications Table 138. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 139. Zhejiang Tianyushan Medicinal Oil Main Business Table 140. Zhejiang Tianyushan Medicinal Oil Latest Developments List of Figures Figure 1. Picture of Pharmaceutical Excipients for Non-injection Figure 2. Pharmaceutical Excipients for Non-injection Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Pharmaceutical Excipients for Non-injection Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Pharmaceutical Excipients for Non-injection Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Pharmaceutical Excipients for Non-injection Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Binders Figure 10. Product Picture of Disintegrants Figure 11. Product Picture of Lubricants Figure 12. Product Picture of Fillers Figure 13. Product Picture of Others Figure 14. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type in 2022 Figure 15. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2018-2023) Figure 16. Pharmaceutical Excipients for Non-injection Consumed in Tablets Figure 17. Global Pharmaceutical Excipients for Non-injection Market: Tablets (2018-2023) & (K Units) Figure 18. Pharmaceutical Excipients for Non-injection Consumed in Capsules Figure 19. Global Pharmaceutical Excipients for Non-injection Market: Capsules (2018-2023) & (K Units) Figure 20. Pharmaceutical Excipients for Non-injection Consumed in Oral Liquids Figure 21. Global Pharmaceutical Excipients for Non-injection Market: Oral Liquids (2018-2023) & (K Units) Figure 22. Pharmaceutical Excipients for Non-injection Consumed in Others Figure 23. Global Pharmaceutical Excipients for Non-injection Market: Others (2018-2023) & (K Units) Figure 24. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2022) Figure 25. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application in 2022 Figure 26. Pharmaceutical Excipients for Non-injection Sales Market by Company in 2022 (K Units) Figure 27. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Company in 2022 Figure 28. Pharmaceutical Excipients for Non-injection Revenue Market by Company in 2022 ($ Million) Figure 29. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Company in 2022 Figure 30. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Geographic Region (2018-2023) Figure 31. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Geographic Region in 2022 Figure 32. Americas Pharmaceutical Excipients for Non-injection Sales 2018-2023 (K Units) Figure 33. Americas Pharmaceutical Excipients for Non-injection Revenue 2018-2023 ($ Millions) Figure 34. APAC Pharmaceutical Excipients for Non-injection Sales 2018-2023 (K Units) Figure 35. APAC Pharmaceutical Excipients for Non-injection Revenue 2018-2023 ($ Millions) Figure 36. Europe Pharmaceutical Excipients for Non-injection Sales 2018-2023 (K Units) Figure 37. Europe Pharmaceutical Excipients for Non-injection Revenue 2018-2023 ($ Millions) Figure 38. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales 2018-2023 (K Units) Figure 39. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue 2018-2023 ($ Millions) Figure 40. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Country in 2022 Figure 41. Americas Pharmaceutical Excipients for Non-injection Revenue Market Share by Country in 2022 Figure 42. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023) Figure 43. Americas Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023) Figure 44. United States Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 45. Canada Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 46. Mexico Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 47. Brazil Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 48. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Region in 2022 Figure 49. APAC Pharmaceutical Excipients for Non-injection Revenue Market Share by Regions in 2022 Figure 50. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023) Figure 51. APAC Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023) Figure 52. China Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 53. Japan Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 54. South Korea Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 55. Southeast Asia Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 56. India Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 57. Australia Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 58. China Taiwan Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 59. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Country in 2022 Figure 60. Europe Pharmaceutical Excipients for Non-injection Revenue Market Share by Country in 2022 Figure 61. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023) Figure 62. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023) Figure 63. Germany Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 64. France Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 65. UK Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 66. Italy Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 67. Russia Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 68. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Country in 2022 Figure 69. Middle East & Africa Pharmaceutical Excipients for Non-injection Revenue Market Share by Country in 2022 Figure 70. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2018-2023) Figure 71. Middle East & Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2018-2023) Figure 72. Egypt Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 73. South Africa Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 74. Israel Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 75. Turkey Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 76. GCC Country Pharmaceutical Excipients for Non-injection Revenue Growth 2018-2023 ($ Millions) Figure 77. Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Non-injection in 2022 Figure 78. Manufacturing Process Analysis of Pharmaceutical Excipients for Non-injection Figure 79. Industry Chain Structure of Pharmaceutical Excipients for Non-injection Figure 80. Channels of Distribution Figure 81. Global Pharmaceutical Excipients for Non-injection Sales Market Forecast by Region (2024-2029) Figure 82. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Region (2024-2029) Figure 83. Global Pharmaceutical Excipients for Non-injection Sales Market Share Forecast by Type (2024-2029) Figure 84. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Type (2024-2029) Figure 85. Global Pharmaceutical Excipients for Non-injection Sales Market Share Forecast by Application (2024-2029) Figure 86. Global Pharmaceutical Excipients for Non-injection Revenue Market Share Forecast by Application (2024-2029)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
LP Information社の医療分野での最新刊レポート
本レポートと同じKEY WORD（pharmaceutical）の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
